Masimo Corporation
NMS: MASILive Quote
📈 ZcoreAI Score
Our AI model analyzes Masimo Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get MASI Z-Score →About Masimo Corporation
Healthcare
Medical Devices
Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
📊 Fundamental Analysis
Masimo Corporation demonstrates a profit margin of -9.9%, which is below the sector average, suggesting competitive pressure.
The company recently reported 12.0% revenue growth, which is above average for the Healthcare sector.
Return on Equity (ROE) is 23.4%, which exceeds the Healthcare sector average, reflecting efficient capital allocation.
At a current price of $178.32, MASI currently trades near the top of its 52-week range (99%) (Range: $125.94 - $179.00).
💰 Valuation Insight
MASI trades at a 86.2% premium to the sector average PE of 25.00. Analysts expect earnings growth, as indicated by a lower forward PE.
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Debt/Equity
Elevated
✅
Revenue Growth
Excellent
⚠️
Return on Equity
Moderate
⚠️
Beta (Risk)
Moderate Volatility
Key Financials
Market Cap
$9.34B
Trailing P/E
46.56
Forward P/E
27.02
Beta (5Y)
1.20
52W High
$179.00
52W Low
$125.94
Avg Volume
1.72M
Day High
Day Low